From: Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Name | Company | Source | Target | Accuracy | Method |
---|---|---|---|---|---|
Alinity i SARS-CoV-2 IgG | Abbott | IgG | NP | IgG Sens 0–7 days: 49.3% 8–13 days: 80.4%  ≥ 14 days: 98.1%, IgG Spec: 99.6% | CLIA |
Architect SARS-CoV-2 IgG | Abbott | IgG | NP | IgG Sens 0–7 days: 49.3% 8–14 days: 82.6%  ≥ 15 days: 98.1%, IgG Spec: 99.6% | CLIA |
AdviseDx SARS-CoV-2 IgM (Architect) | Abbott | IgM | S | IgM Sens 0–7 days: 42.6% 8–14 days: 79%  ≥ 15 days: 95%, IgM Spec: 99.6% | CLIA |
Babson Diagnostics aC19G1 | Babson Diagnostics, Inc | IgG | S | IgG Sens 8–14 days: 66.7%  ≥ 15 days: 100% IgG Spec: 100% | CLIA |
Access SARS-CoV-2 IgG | Beckman Coulter, Inc | IgG | S | IgG Sens 0–7 days: 75.8% 8–14 days: 95.3%  ≥ 15 days: 96.8%, IgG Spec: 99.6% | CLIA |
Access SARS-CoV-2 IgM | Beckman Coulter, Inc | IgM | S | IgM Sens 0–7 days: 54.4% 8–14 days: 91.7%  ≥ 15 days: 98.3%, IgM Spec: 99.9% | CLIA |
SARS-CoV-2 IgG and IgM Combo Test | BioCheck, Inc | IgM, IgG | S | IgM Sens 0–7 days: 100% 8–14 days: 93.8%  ≥ 15 days: 88.9%, IgM Spec: 97.2% IgG Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 100% | CLIA |
SARS-CoV-2 IgG Antibody Test Kit | BioCheck, Inc | IgG | S | IgG Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 100% | CLIA |
SARS-CoV-2 IgM Antibody Test Kit | BioCheck, Inc | IgM | S | IgM Sens 0–7 days: 100% 8–14 days: 93.8%  ≥ 15 days: 88.9%, IgM Spec: 97.2% | CLIA |
LIAISON SARS-CoV-2 IgM Assay | DiaSorin, Inc | IgM | S | IgM Sens 0–7 days: 64.4% 8–14 days: 90.2%  ≥ 15 days: 92.6%, IgM Spec: 99.3% | CLIA |
LIAISON SARS-CoV-2 S1/S2 IgG | DiaSorin, Inc | IgG | S | IgG Sens 0–5 days: 25% 6–14 days: 89.8%  ≥ 15 days: 97.55%, IgG Spec: 99.3% | CLIA |
LIAISON SARS-CoV-2 TrimericS IgG | DiaSorin, Inc | IgG | S | IgG Sens 0–7 days: 21.4% 8–14 days: 70.8%  ≥ 15 days: 96.9%, IgG Spec: 99.5% | CLIA |
DZ-Lite SARS-CoV-2 IgG CLIA Kit | Diazyme Laboratories, Inc | IgG | S, NP | IgG Sens 0–7 days: 43.5% 8–14 days: 91.7%  ≥ 15 days: 100%, IgG Spec: 97.4% | CLIA |
DZ-Lite SARS-CoV-2 IgM CLIA Kit | Diazyme Laboratories, Inc | IgM | S, NP | IgG Sens 0–7 days: 26.1% 8–14 days: 83.8%  ≥ 15 days: 94.4%, IgG Spec: 98.3% | CLIA |
QUANTA Flash SARS-CoV-2 IgG | Inova Diagnostics, Inc | IgG | S, NP | IgG Sens 0–7 days: 66.7% 8–14 days: 61.5%  ≥ 15 days: 100%, IgG Spec: 99.9% | CLIA |
VITROS Anti-SARS-CoV-2 IgG test | Ortho-Clinical Diagnostics, Inc | IgG | S | IgG Sens 12–15 days: 83.3%  ≥ 16 days: 90%, IgG Spec: 100% | CLIA |
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent | Ortho-Clinical Diagnostics, Inc | Pan-Ig | S | Pan-Ig Sens 0–7 days: 80%  ≥ 8 days: 100%, Pan-Ig Spec: 100% | CLIA |
Q-Plex SARS-CoV-2 Human IgG (4 Plex) | Quansys Biosciences, Inc | IgG | S | IgG Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 95.2%, IgG Spec: 99.7% | CLIA |
MAGLUMI 2019-nCoV IgM/IgG | Shenzhen New Industries Biomedical Engineering Co., Ltd | IgM, IgG | S, NP | IgM Sens 0–7 days: 43.8% 8–14 days: 78.3%  ≥ 15 days: 77.5%, IgM Spec: 99.6% IgG Sens 0–7 days: 31.3% 8–14 days: 90.6%  ≥ 15 days: 100%, IgG Spec: 99.1% | CLIA |
ADVIA Centaur SARS-CoV-2 IgG (COV2G) | Siemens Healthcare Diagnostics | IgG | S | IgG Sens 0–6 days: 53.5% 7–13 days: 93.4%  ≥ 14 days: 100%, IgG Spec: 99.9% | CLIA |
ADVIA Centaur SARS-CoV-2 Total (COV2T) | Siemens Healthcare Diagnostics | Pan-Ig | S | IgG Sens 0–6 days: 61.1% 7–13 days: 97.5%  ≥ 14 days: 100%, IgG Spec: 99.8% | CLIA |
Atellica IM SARS-CoV-2 IgG (COV2G) | Siemens Healthcare Diagnostics | IgG | S | IgG Sens 0–6 days: 56% 7–13 days: 92.2%  ≥ 14 days: 100%, IgG Spec: 99.9% | CLIA |
Atellica IM SARS-CoV-2 Total (COV2T) | Siemens Healthcare Diagnostics | Pan-Ig | S | Pan-Ig Sens 0–6 days: 60.7% 7–13 days: 97.5%  ≥ 14 days: 100%, Pan-Ig Spec: 99.8% | CLIA |
Vibrant COVID-19 Ab Assay | Vibrant America Clinical Labs | Pan-Ig | S, NP | IgG/IgM Sens: 98.1%, IgG/IgM Spec: 98.6% | CLIA |
WANTAI SARS-CoV-2 Ab ELISA | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Pan-Ig | S | Pan-Ig Sens 0–7 days: 55.4% 8–14 days: 84.8%  ≥ 15 days: 98.7%, Pan-Ig Spec: 97.5% | ELISA |
Platelia SARS-CoV-2 Total Ab | Bio-Rad Laboratories, Inc | Pan-Ig | NP | Pan-Ig Sens 0–7 days: 100% 8–14 days: 96%  ≥ 15 days: 100%, Pan-Ig Spec: 99.3% | ELISA |
SARS-CoV-2 RBD IgG test | Emory Medical Laboratories | IgG | S | IgG Sens 0–7 days: 73% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 97.7% | ELISA |
SARS-CoV-2 ELISA (IgG) | EUROIMMUN | IgG | S | IgG Sens 0–4 days: 21.7% 5–10 days: 69.4%  ≥ 11 days: 81.1%, IgG Spec: 100% | ELISA |
cPass SARS-CoV-2 Neutralization Antibody Detection Kit | GenScript USA Inc | Pan-Ig | S | Pan-Ig Sens: 100%, Pan-Ig Spec: 100% | ELISA |
SCoV-2 Detect IgG ELISA | InBios International, Inc | IgG | S | IgG Sens 8–14 days: 100%  ≥ 15 days: 95.5%, IgG Spec: 100% | ELISA |
SCoV-2 Detect IgM ELISA | InBios International, Inc | IgM | S | IgM Sens 0–7 days: 66.7% 8–14 days: 91.4%  ≥ 15 days: 93.8%, IgM Spec: 98.8% | ELISA |
COVID-SeroKlir, Kantaro Semi-Quantitative SARS-CoV-2 IgG Antibody Kit | Kantaro Biosciences, LLC | IgG | S | IgG Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 93%, IgG Spec: 99.6% | ELISA |
Mt. Sinai Laboratory COVID-19 ELISA Antibody Test | Mount Sinai Hospital Clinical Laboratory | IgM, IgG | S | Combined Sens: 92.5%, Combined Spec: 100% | ELISA |
Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test | Quanterix Corporation | IgG | S | IgG Sens 0–7 days: 45.2% 8–14 days: 87.5%  ≥ 15 days: 100%, IgG Spec: 99.2% | ELISA |
Dimension Vista SARS-CoV-2 Total Ab assay (COV2T) | Siemens Healthcare Diagnostics | Pan-Ig | S | Pan-Ig Sens 0–6 days: 66.7% 7–13 days: 97.4%  ≥ 14 days: 100%, Pan-Ig Spec: 99.8% | ELISA |
Dimension EXL SARS-CoV-2 Total Ab assay (CV2T) | Siemens Healthcare Diagnostics | Pan-Ig | S | Pan-Ig Sens 0–6 days: 68.8% 7–13 days: 97.4%  ≥ 14 days: 100%, Pan-Ig Spec: 99.9% | ELISA |
COVID-19 self-collected Ab test system | Symbiotica, Inc | IgG | S | IgG Sens 8–14 days: 100%  ≥ 15 days: 100%, Pan-Ig Spec: 98.04% | ELISA |
OmniPATH COVID-19 Total Antibody ELISA Test | Thermo Fisher Scientific | Pan-Ig | S | Pan-Ig Sens 0–7 days: 19% 8–14 days: 76.7%  ≥ 15 days: 100%, Pan-Ig Spec: 100% | ELISA |
COVID-19 ELISA pan-Ig Antibody Test | University of Arizona Genetics Core for Clinical Services | Pan-Ig | S | Pan-Ig Sens  ≥ 15 days: 97.5%, Pan-Ig Spec: 99.1% | ELISA |
ZEUS ELISA SARS-CoV-2 Total Test | ZEUS Scientific, Inc | Pan-Ig | S | Pan-Ig Sens: 93.3%, Pan-Ig Spec: 100% | ELISA |
ZEUS ELISA SARS-CoV-2 IgG Test System | ZEUS Scientific, Inc | IgG | S | IgG Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 99.1% | ELISA |
CareStart COVID-19 IgM/IgG | Access Bio, Inc | IgM, IgG | S, NP | IgM Sens 8–14 days: 100%  ≥ 15 days: 88.7%, IgM Spec: 99.5% IgG Sens 8–14 days: 100%  ≥ 15 days: 96.8%, IgG Spec: 99.5% | LFIA |
Assure COVID-19 IgG/IgM Rapid Test Device | Assure Tech | IgM, IgG | S, NP | IgG/IgM Sens 0–7 days: 100% 8–14 days: 83.3%  ≥ 15 days: 89.3%, IgG/IgM Spec: 100% | LFIA |
ACON SARS-CoV-2 IgG/IgM Rapid Test | ACON Laboratories, Inc | IgM, IgG | S, NP | IgG/IgM Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 100%, IgG/IgM Spec: 95.9% | LFIA |
RapCov Rapid COVID-19 Test | ADVAITE, Inc | IgG | NP | IgG Sens  ≥ 15 days: 93.3%, IgG Spec: 99.5% | LFIA |
WANTAI SARS-CoV-2 Ab Rapid Test | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Pan-Ig | S | Pan-Ig Sens: 100%, Pan-Ig Spec: 98.8% | LFIA |
Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test | Biocan Diagnostics Inc | IgM, IgG | S, NP | IgM Sens 8–14 days: 88.9%  ≥ 15 days: 85.2%, IgM Spec: 98.7% IgG Sens 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 96.2% | LFIA |
Biohit SARS-CoV-2 IgM/IgG Antibody Test Kit | Biohit Healthcare (Hefei) | IgM, IgG | NP | IgM Sens 0–7 days: 33.3% 8–14 days: 83%  ≥ 15 days: 97.7%, IgM Spec: 99.5% IgG Sens 8–14 days: 56.6%  ≥ 15 days: 96.2%, IgG Spec: 100% | LFIA |
qSARS-CoV-2 IgG/IgM Rapid Test | Cellex, Inc | IgM, IgG | S, NP | Combined Sens: 93.8%, Combined Spec: 96% | LFIA |
COvAb SARS-CoV-2 Ab Test | Diabetomics, Inc | Pan-Ig | S | Pan-Ig Sens 0–7 days: 41.6% 8–14 days: 84.2%  ≥ 15 days: 97.6%, Pan-Ig Spec: 98.78% | LFIA |
RightSign COVID-19 IgG/IgM Rapid Test Cassette | Hangzhou Biotest Biotech | IgM, IgG | S | IgG/IgM Sens 0–7 days: 66.7% 8–14 days: 100%  ≥ 15 days: 88.9%, IgG/IgM Spec: 100% | LFIA |
LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo | Hangzhou Laihe Biotech | IgM, IgG | S | IgM Sens 0–6 days: 100% 7–14 days: 85.7%  ≥ 15 days: 99.3%, IgM Spec: 99.4% IgG Sens 7–14 days: 76.2%  ≥ 15 days: 98.5%, IgG Spec: 99.4% | LFIA |
COVID-19 IgG/IgM Rapid Test Cassette | Healgen Scientific, LLC | IgM, IgG | S | IgM Sens: 100%, IgM Spec: 100% IgG Sens: 96.7%, IgG Spec: 97.5% Combined Sens: 100%, Combined Spec: 97.5% | LFIA |
Innovita 2019-nCoV Ab Test (Colloidal Gold) | Innovita (Tangshan) Biological Technology Co., Ltd | IgM, IgG | S, NP | IgG/IgM Sens 0–7 days: 87.9% 8–14 days: 96.6%  ≥ 15 days: 100%, IgG/IgM Spec: 98% | LFIA |
SCoV-2 Detect IgG Rapid Test | InBios International, Inc | IgG | S | IgG Sens 0–7 days: 92.9% 8–14 days: 81.8%  ≥ 15 days: 100%, IgG Spec: 97.7% | LFIA |
Orawell IgM/IgG Rapid Test | Jiangsu Well Biotech | IgM, IgG | S | IgG/IgM Sens 8–14 days: 98.2%  ≥ 15 days: 100%, IgG/IgM Spec: 98% | LFIA |
Rapid COVID-19 IgM/IgG Combo Test Kit | Megna Health, Inc | IgM, IgG | NP | IgM Sens 0–7 days: 66.7% 8–14 days: 77.1%  ≥ 15 days: 90.9%, IgM Spec: 99.6% IgG Sens 0–7 days: 62.3% 8–14 days: 85.7%  ≥ 15 days: 90.9%, IgG Spec: 99.3% | LFIA |
Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit | Nirmidas Biotech, Inc | IgM, IgG | S | IgG Sens 0–7 days: 27.8% 8–14 days: 76.5%  ≥ 15 days: 100%, IgM Sens 0–7 days: 27.8% 8–14 days: 82.4%  ≥ 15 days: 97%, IgM/IgG Spec: 84.8% | LFIA |
ADEXUSDx COVID-19 Test | NOWDiagnostics, Inc | Pan-Ig | S | Pan-Ig Sens: 93.3%, Pan-Ig Spec: 100% | LFIA |
QIAreach Anti-SARS-CoV-2 Total Test | QIAGEN, GmbH | Pan-Ig | S | Pan-Ig Sens: 100% Pan-Ig Spec: 97.5% | LFIA |
Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette | Salofa Oy | IgM, IgG | S | IgM Sens: 90%, IgM Spec: 100% IgG Sens: 93.3%, IgG Spec: 98.8% Combined Sens: 93.3%, Combined Spec: 98.8% | LFIA |
SGTi-flex COVID-19 IgG | Sugentech, Inc | IgG | S, NP | IgG Sens 0–7 days: 41.2% 8–14 days: 91.7%  ≥ 15 days: 98.6%, IgG Spec: 100% | LFIA |
TBG SARS-CoV-2 IgG/IgM Rapid Test Kit | TBG Biotechnology Corp | IgM, IgG | S, NP | IgM/IgG Sens  ≥ 15 days: 96.4%, IgM/IgG Spec: 99.8% | LFIA |
BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test | Xiamen Biotime Biotechnology Co., Ltd | IgM, IgG | S | IgM Sens 0–7 days: 55.1% 8–14 days: 94.1%  ≥ 15 days: 100%, IgG Sens 0–7 days: 46.4% 8–14 days: 67.7%  ≥ 15 days: 100%, IgM/IgG Spec: 98.5% | LFIA |
VIDAS SARS-CoV-2 IgG | BioMérieux SA | IgG | S | IgG Sens 0–7 days: 47.9% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 99.9% | ELFA |
VIDAS SARS-CoV-2 IgM | BioMérieux SA | IgM | S | IgM Sens 0–7 days: 53.8% 8–14 days: 100%  ≥ 15 days: 100%, IgG Spec: 99.4% | ELFA |
Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 | Genalyte, Inc | Pan-Ig | S, NP | Ig Sen 0–7 days: 66.7% 8–14 days: 90.9%  ≥ 15 days: 96.1%, Ig Spec: 97.7% | PRI |
xMAP SARS-CoV-2 Multi-Antigen IgG Assay | Luminex Corporation | IgG | S, NP | IgG Sens 0–7 days: 71.1% 8–14 days: 71.4%  ≥ 15 days: 96.2%, IgG Spec: 100% | FMIA |
BioPlex 2200 SARS-CoV-2 IgG | Bio-Rad Laboratories | IgG | S | IgG Sens 0–7 days: 81.3% 8–14 days: 96.3%  ≥ 15 days: 93.9%, IgG Spec: 99.9% | FIA |
FREND COVID-19 total Ab | NanoEntek America, Inc | IgM, IgG | NP | Combined Sens: 96.7%, Combined Spec: 98.8% | FIA |
MosaiQ COVID-19 Antibody Magazine | Quotient Suisse SA | Pan-Ig | S | Ig Sens 0–7 days: 100% 8–14 days: 100%  ≥ 15 days: 93%, Ig Spec: 99.8% | PIA |
Elecsys Anti-SARS-CoV-2 | Roche Diagnostics, Inc | Pan-Ig | NP | Ig Sens 0–6 days: 60.2% 7–13 days: 85.3%  ≥ 14 days: 99.5%, Ig Spec.: 99.7% | ECLIA |
Elecsys Anti-SARS-CoV-2 S | Roche Diagnostics, Inc | Pan-Ig | S | Ig Sens 0–7 days: 90.6% 8–14 days: 87%  ≥ 15 days: 96.6%, Ig Spec.: 100% | ECLIA |
New York SARS-CoV Microsphere Immunoassay for Antibody | Wadsworth Center, New York State Department of Health | Pan-Ig | NP | Ig Sens 0–6 days: 17.9% 7–10 days: 31.3% 11–15 days: 48.9% 16–20 days: 49.2%  > 20 days: 79.3%, Ig Spec: 99.6% | MIA |